Headlines

CELYAD ONCOLOGY Stock 10% Up On Tuesday

(VIANEWS) – The Market ended the session with CELYAD ONCOLOGY (CYAD.BR) rising 10% to €0.57 on Tuesday, following the last session’s upward trend. BEL 20 dropped 0.46% to €3,699.10, following the last session’s downward trend on what was a somewhat bearish trend trading session today. About CELYAD ONCOLOGY Celyad Oncology SA, a clinical-stage biopharmaceutical company,…

Read More

CROSSWOOD Stock Went Up By Over 28% In The Last 21 Sessions

Crosswood (CROS.PA), a reputable Real Estate Company of France, has been in the spotlight recently due to its grand performance in the stock market. Known for possessing a prominent portfolio that includes assets such as offices, residential properties and shopping outlets, this establishment operates as a subsidiary of the esteemed Compagnie Financiere De Broceliande. The…

Read More

CELYAD ONCOLOGY Stock Bullish Momentum With A 10% Jump So Far On Tuesday

Celyad Oncology’s (CYAD.BR) stocks experienced an unexpected surge on the BEL 20 market index on Tuesday. The company saw a ten percent increase in their stock’s value, climbing up to EUR0.57. This substantial rise starkly contrasted the overall market trend which followed a downward trajectory, with the market index falling by 0.3% to EUR3,704.94. Hence,…

Read More